Spotlighting our presentations at the Precision Medicine World Conference 2023 

Kicking off the new year, the annual Precision Medicine World Conference (PMWC) took place in-person at the Santa Clara Convention Center in Santa Clara, California from January 25-27, 2023. PMWC is the largest international meeting of experts dedicated to precision medicine. At this conference, OraSure Technologies, Inc. had speakers on behalf of its subsidiary companies […]

Mars Petcare And Diversigen Collaborate In One Of The Largest Ever Microbiome Studies To Evaluate Pet Health

OraSure Partners with Mars Petcare in One of the Largest Ever Microbiome Studies to Evaluate Pet Health BETHLEHEM, Pa., September 14, 2022 (Globe Newswire) – OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies, announced today a new collaboration between Diversigen, Inc., a subsidiary of OraSure […]

Prolacta Bioscience publishes new research showing reversible engraftment using a synbiotic of B. infantis and HMO in healthy adult microbiomes without antibiotics

Prolacta Bioscience has published new research successfully using a synbiotic of human milk oligosaccharides (HMOs) with Bifidobacterium longum subsp. infantis (B. infantis) to reversibly engraft the microbe within healthy human adult microbiomes without the use of antibiotics. Within the infant microbiome, HMOs are uniquely metabolized by B. infantis to produce short-chain fatty acids such as […]

Leading Microbiome Researcher Dr. Eric Pamer Joins Diversigen’s Scientific Advisory Board

Leading Microbiome Researcher Dr. Eric Pamer   Joins Diversigen’s Scientific Advisory Board Joins Diversigen’s Scientific Advisory Board Leading Microbiome Researcher Dr. Eric Pamer   Joins Diversigen’s Scientific Advisory Board PAUL, MN, January 25, 2021 – Diversigen, Inc., a subsidiary of OraSure Technologies Inc.  (NASDAQ: OSUR), today announced that Eric Pamer, M.D., Professor of Medicine, Section of  Infectious […]

Former CEO of H2O+ Beauty, Former Chief Chemist of MAC Cosmetics Launch Innovative Skincare Brand Using First-Ever Scientific Microbiome Testing

Pure Culture Beauty delivers a clean, customized skincare regimen formulated to enhance consumers’ skin health SAN FRANCISCO, Sept. 15, 2020 (GLOBE NEWSWIRE) — Today, Joy Chen, former CEO of H2O+ Beauty, and Victor Casale, former Chief Chemist of MAC Cosmetics and co-founder of CoverFX, announced the launch of Pure Culture Beauty, the first skincare brand using […]

Diversigen, Inc. and Alimentiv Inc. Announce Collaboration Agreement for Ulcerative Colitis Research Study

ST. PAUL, MN, June 25, 2020 – Diversigen, Inc., a subsidiary of OraSure Technologies Inc. (NASDAQ:OSUR), and Alimentiv Inc. (formerly Robarts Clinical Trials) today announced they have signed a collaboration agreement for a research study on patients with Acute Severe Ulcerative Colitis (ASUC). The study, titled: “Pharmacokinetics of Infliximab and Tumor Necrosis Factor Concentrations in […]

Diversigen Inc. Selected by Nom NomTM as the Preferred Provider for Metagenomics and Microbiome Sequencing and Analysis Services

PAUL, MN and OAKLAND, CA, May 22, 2020 – Diversigen, Inc., a subsidiary of OraSure Technologies Inc. (NASDAQ:OSUR), and Nom NomTM, a direct-to-consumer pet health brand, today announced that Nom Nom has selected Diversigen as their preferred provider for metagenomics and microbiome sequencing and analysis services. Diversigen will also serve as Nom Nom’s central lab […]

OraSure Technologies, Inc. Consolidates Microbiome Services Subsidiaries

OraSure Technologies, Inc. announces that its Diversigen and CoreBiome subsidiaries have combined their microbiome service offerings under the Diversigen name. The rebrand highlights the combined companies’ unparalleled scientific bench strength, state-of-the-art laboratory, ability to translate data to insights and collective focus on quality and service.   Investor Contact: Roberto Cuca Chief Financial Officer 610-882-1820 investorinfo@orasure.com Media Contact: […]

Diversigen bioinformatics team publishes review on the human virome and disease

“The virome is comprised of endogenous retroviruses, eukaryotic viruses, and bacteriophages and is increasingly being recognized as an essential part of the human microbiome. The human virome is associated with Type-1 diabetes (T1D), Type-2 diabetes (T2D), Inflammatory Bowel Disease (IBD), Human Immunodeficiency Virus (HIV) infection, and cancer. Increasing evidence also supports trans-kingdom interactions of viruses […]